Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: Implication of α1- and α2-adrenoceptors

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 578-584

  Laorden, Maria Luisa ^a   Fuertes, Gregorio ^a   González Cuello, Ana ^a   Milanés, Maria Victoria ^a  

^a UNIVERSITY OF MURCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; CORTICOSTERONE; DOPAMINE; MORPHINE; NALOXONE; NORADRENALIN; PRAZOSIN; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE METABOLISM; CATECHOLAMINERGIC SYSTEM; CORTICOSTERONE RELEASE; DRUG WITHDRAWAL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MORPHINE ADDICTION; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; THALAMUS MIDLINE NUCLEUS;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; AUTONOMIC PATHWAYS; CATECHOLAMINES; CORTICOSTERONE; DOPAMINE; MALE; MORPHINE DEPENDENCE; NALOXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; PRAZOSIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RECEPTORS, ADRENERGIC, ALPHA-2; YOHIMBINE;

EID: 0034016153     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Aghajanian GK and Wang YY (1978) Common alpha-2 and opiate effector mechanisms in the locus coeruleus: Intracellular studies in brain slices. Neuropharmacology 26:789-800.
2. Artigas F, Sarrias MJ, Adell A and Gelpí E (1986) Quantitation of total MHPG in the rat brain using a non enzymatic hydrolysis procedure. Effects of drugs. Life Sci 39:1571-1578.
3. Berhow MT, Russel DS, Terwilliger RZ, Beitner-Johnson D, Self DW, Lindsay RM and Nestler EJ (1995) Influence of neurotrophic factors on morphine-and cocaine-induced biochemical changes in the mesolimbic dopamine system. Neuroscience 68:969-979.
4. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR and Trendelenburg U (1994) IV. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46:121-136.
5. Chieng B and Christie MJ (1996) Local opioid withdrawal in rat single periaqueductal gray neurons in vitro. J Neurosci 16:7128-7136.
6. Couceyro P and Douglass J (1995) Precipitated morphine withdrawal stimulates multiple activator protein-1 signaling pathways in rat brain. Mol Pharmacol 47:29-39.
7. Cunningham ET and Sawchenko PE (1988) Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J Comp Neurol 274:60-76.
8. Giralt MT and Garcia-Sevilla JA (1989) Acute and long-term regulation of brain alpha 2-adrenoceptors after manipulation of noradrenergic transmission in the rat. Eur J Pharmacol 164:455-466.
9. Gonzálvez ML, Milanés MV, Martínez-Piñero MG, Marín MT and Vargas ML (1994) Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal. Brain Res 647:199-203.
10. Gunion MW, Rosenthal MJ, Miller S, Hoyt MA and Yonzon DB (1992) Role of hypothalamic paraventricular nucleus α-and β-adrenergic receptors in regulation of blood glucose, free fatty acids and corticosterone. Brain Res 588:84-96.
11. Ignar DM and Kuhn CM (1990) Effects of specific Mu and Kappa opiate tolerance and abstinence on hypothalamo-pituitary-adrenal axis secretion in the rat. J Pharmacol Exp Ther 255:1287-1295.
12. Itoi K, Suda T, Tozawa F, Dobashi I, Ohmori N, Sakai Y, Abe K and Demura H (1994) Microinjection of norepinephrine into the paraventricular nucleus of the hypothalamus stimulates corticotropin-releasing factor gene expression in conscious rats. Endocrinology 135:2177-2182.
13. 1-adrenergic receptor stimulation of phosphoinositol hydrolysis in hypothalamus of estrogen-primed female rats. Endocrinology 136:1993-1999.
14. Lightman SL and Young WS (1988) Corticotropin-releasing factor, vasopressin and pro-opiomelanocortin mRNA responses to stress and opiates in the rat. J Physiol 403:511-523.
15. Liposits ZS and Paull WK (1989) Association of dopaminergic fibers with corticotropin releasing hormone (CRH)-synthesizing neurons in the paraventricular nucleus of the rat hypothalamus. Histochemistry 93:119-127.
16. Lookingland KJ, Ireland LM, Gunnet JW, Manzanares J, Tian Y and Moore KE (1991) 3-Methoxy-4-hydroxyphenylethyleneglycol concentrations in discrete hypothalamic nuclei reflect the activity of noradrenergic neurons. Brain Res 559:82-88.
17. Maldonado R, Stinus L, Gold LH and Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677.
18. Manzanares J, Lookingland KJ and Moore KE (1990) Kappa-opioid receptor-mediated regulation of α-melanocyte stimulating hormone secretion and tuberohypophysial dopaminergic neuronal activity. Neuroendocrinology 52:200-205.
19. Martínez-Piñero MG, Milanés MV, Alcaraz C and Vargas ML (1994) Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: Implication of α-and β-adrenoceptors. Brain Res 668:122-128.
20. Martínez JA, Vargas ML, Fuente T, del Río-García J and Milanés MV (1990) Plasma β-endorphin and cortisol levels in morphine-tolerant rats and in naloxone-induced withdrawal. Eur J Pharmacol 182:117-123.
21. Milanés MV, Laorden ML, Chapleur-Chateau M and Burlet A (1998) Alterations in corticotropin-releasing factor and vasopressin content in rat brain during morphine withdrawal. Correlation with hypothalamic noradrenergic activity and pituitary-adrenal response. J Pharmacol Exp Ther 285:700-706.
22. Nestler EJ, Hope BT and Widnell KL (1993) Drug addiction: A model for molecular basis of neural plasticity. Neuron 11:995-1006.
23. Palkovits M (1973) Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res 59:449-450.
24. Palkovits M and Brownstein MJ (1988) Maps and Guide to Microdissection of the Rat Brain. Elsevier Publishing Co, New York.
25. Pechnick RN (1993) Effects of opioids on the hypothalamo-pituitary-adrenal axis. Annu Rev Pharmacol Toxicol 32:353-382.
26. Plotsky PM (1987) Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection. Endocrinology 121:924-930.
27. Rasmussen K, Beitner-Johnson DB, Krystal JH, Aghajanian GK and Nestler EJ (1990) Opiate withdrawal and the rat locus coeruleus: Behavioral, electrophysiological, and biochemical correlates. J Neurosci 10:2308-2317.
28. Self DW and Nestler EJ (1995) Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 18:463-495.
29. 2-adrenoceptors. Ann NY Acad Sci 430:55-59.
30. 2-receptors. Naunyn-Schmiedeberg's Arch Pharmacol 329:293-298.
31. Vargas ML, Martínez-Piñero MG and Milanés MV (1997) Neurochemical activity of noradrenergic neurons and pituitary-adrenal response after naloxone-induced withdrawal: The role of calcium channels. Naunyn-Schmiedeberg's Arch Pharmacol 355:501-506.